Trials / Completed
CompletedNCT01023178
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure
Comparison of Transdermal and Oral Estrogens in Adolescents With Ovarian Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Female
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.
Detailed description
Treatment with transdermal 17beta(17β) estradiol resulted in higher estradiol levels and more effective feminization compared to oral conjugated equine estrogen but did not result in an otherwise different biochemical profile in this limited number of heterogeneous patients. OBE (oral beta estradiol) and TBE (transdermal beta estradiol) provide safe and effective alternatives to OCEE (oral conjugated equine estrogen) to induce puberty in girls, but larger prospective randomized trials are required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 17beta Estradiol | Oral pill given daily at increasing doses every 6 months for 18 months. |
| DRUG | Conjugated estrogens | Oral pill, started at a low dose taken daily, dose increased every 6 months for 18 months |
| DRUG | 17Beta Estradiol - transdermal | Transdermal estrogen patch, started at low dose with increasing doses eery 6 months for 18 months |
| DRUG | Progesterone, micronized | Given starting at 18 months |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2009-12-02
- Last updated
- 2017-01-20
- Results posted
- 2017-01-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01023178. Inclusion in this directory is not an endorsement.